Panjon Pharma Ltd. reported unaudited earnings results for the third quarter and nine months ended December 31, 2012. For the quarter, the company reported total income from operations of INR 50,665,000 against INR 40,824,000 for the same period last year. Profit from operations before other income, finance costs and exceptional items was INR 50,665,000 against INR 40,824,000 for the same period last year. Profit from ordinary activities before tax was INR 386,000 against INR 465,000 for the same period last year. Net profit for the period was INR 386,000 or INR 0.03 per basic and diluted share against INR 465,000 or INR 0.03 per basic and diluted share for the same period last year.

For the nine months, the company reported total income from operations of INR 138,256,000 against INR 104,954,000 for the same period last year. Profit from operations before other income, finance costs and exceptional items was INR 138,256,000 against INR 104,954,000 for the same period last year. Profit from ordinary activities before tax was INR 1,101,000 against INR 880,000 for the same period last year. Net profit for the period was INR 1,101,000 or INR 0.03 per basic and diluted share against INR 880,000 or INR 0.03 per basic and diluted share for the same period last year.